#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5030928	A	Stability in human plasma assessed as half life measured upto 48 hrs by RP-HPLC analysis	Homo sapiens	3	ALA5030512	cell-free format	Scientific Literature
2.	ALA5030931	A	Drug metabolism in 5 mM GSH assessed as 5-FU release after 4 hrs		1	ALA5030512	assay format	Scientific Literature
3.	ALA5030932	A	Drug metabolism in 5 mM GSH assessed as 5-FU release after 48 hrs		3	ALA5030512	assay format	Scientific Literature
4.	ALA5030933	A	Drug metabolism in 1 mM GSH assessed as 5-FU release after 4 hrs		1	ALA5030512	assay format	Scientific Literature
5.	ALA5030934	P	Half life of the compound in 1 mM GSH		1	ALA5030512	small-molecule physicochemical format	Scientific Literature
6.	ALA5030935	P	Half life of the compound in 5 mM GSH		1	ALA5030512	small-molecule physicochemical format	Scientific Literature
7.	ALA5030936	A	Drug degradation in 5 uM GSH after 48 hrs		1	ALA5030512	assay format	Scientific Literature
8.	ALA5030938	F	Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability measured after 48 hrs by SRB assay	Homo sapiens	9	ALA5030512	cell-based format	Scientific Literature
9.	ALA5030939	F	Cytotoxicity against human HT-29 cells assessed as reduction in cell viability measured after 48 hrs by SRB assay	Homo sapiens	9	ALA5030512	cell-based format	Scientific Literature
10.	ALA5030940	F	Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability measured after 48 hrs in presence of 5 mM GSH by SRB assay	Homo sapiens	9	ALA5030512	cell-based format	Scientific Literature
11.	ALA5030941	F	Cytotoxicity against human HT-29 cells assessed as reduction in cell viability measured after 48 hrs in presence of 5 mM GSH by SRB assay	Homo sapiens	9	ALA5030512	cell-based format	Scientific Literature
12.	ALA5030946	A	Cytotoxicity against NHDF assessed as reduction in cell viability measured after 48 hrs by SRB assay	Homo sapiens	2	ALA5030512	cell-based format	Scientific Literature
13.	ALA5030947	F	Antitumour activity against human colorectal cancer cells xenografted in BALB/c mouse assessed as tumour suppression at 50 mg/kg, ip administered once every 3 days for 3 weeks	Mus musculus	2	ALA5030512	organism-based format	Scientific Literature
14.	ALA5030948	T	Toxicity in BALB/c mouse xenografted with human colorectal cancer cells assessed as reduction in body weight at 50 mg/kg, ip administered once every 3 days for 3 weeks	Mus musculus	2	ALA5030512	organism-based format	Scientific Literature
15.	ALA5030950	A	Drug metabolism in BALB/c mouse assessed as release of 5-FU in blood at 50 mg/kg, iv measured after 2 hrs by UPLC-MS/MS analysis	Mus musculus	1	ALA5030512	organism-based format	Scientific Literature
16.	ALA5030951	A	Drug uptake in BALB/c mouse blood at 50 mg/kg, iv measured after 30 mins by UPLC-MS/MS method	Mus musculus	1	ALA5030512	organism-based format	Scientific Literature
17.	ALA5030952	A	Drug uptake in BALB/c mouse blood at 50 mg/kg, iv measured after 45 mins by UPLC-MS/MS method	Mus musculus	1	ALA5030512	organism-based format	Scientific Literature
18.	ALA5030953	A	Drug uptake in BALB/c mouse blood at 50 mg/kg, iv measured after 4 hrs by UPLC-MS/MS method	Mus musculus	1	ALA5030512	organism-based format	Scientific Literature
19.	ALA5030954	A	Tmax in BALB/c mouse at 50 mg/kg, ip by LC-MS/MS analysis	Mus musculus	1	ALA5030512	organism-based format	Scientific Literature
20.	ALA5030955	A	Biodistribution in BALB/c mouse stomach at 50 mg/kg, ip measured after 1 hr	Mus musculus	2	ALA5030512	organism-based format	Scientific Literature